A schematic representation of the experiment design is shown in the figure. Fifteen dams were allocated to each treatment group. PAE mice were exposed to ethanol (10% vol/vol in non-acidified …
(a) Dam weight progression was significantly affected by HMD but not PAE by quadratic mixed effects model without interaction. (b) Trajectory of liquid consumption across pregnancy was affected by …
There was no significant difference in the average gain of weight in dams between (a) days 1–17 and (b) days 1–19 by treatment group. Both timepoints were included due to some pregnancies ending by …
The figure shows methylation levels averaged across cytosine-guanines (CpGs) in different regulatory genomic contexts. Neither brain tissue (a and b) nor liver tissue (c and d) were grossly affected …
The majority of differentially methylated regions (DMRs) lost methylation with PAE in (a) brain and (b) liver of mice given normal chow (NC). Each point represents one DMR. Point colour indicates …
Average DNA methylation effect sizes above 30% with PAE were observed in some (a) brain and (b) liver differentially methylated regions (DMRs) in normal chow (NC) mice. Mean absolute difference in …
PAE and HMD had no significant effect on anxiety as evident by no significant difference by unpaired t-test in the (a) percent time in the inner zone in the open field test (N=104) and (b) percent …
HMD was associated with increased locomotor activity compared to NC, indicated by significantly greater total distance travelled in the (a) open field test (N=104), (b) object recognition test …
Examples of two PAE DMRs that had significantly lower DNA methylation with a clinical diagnosis of FASD in the Lussier et al., 2018 cohort (a and c), while their mouse liftover DMR also had …
Δmeth indicates the percentage change in average methylation level within the DMR with prenatal alcohol exposure (PAE) compared to non-PAE mice.
Gene | Tissue | Intronic DMR | Width | No. CpGs | Δmeth | p-Value |
---|---|---|---|---|---|---|
Auts2 | Brain | chr5:131510296–131510465 | 170 | 5 | –23.5% | <0.05 |
Auts2 | Liver | chr5:131621828–131621999 | 172 | 4 | –22.5% | <0.05 |
Adgb | Brain | chr10:10455557–10455883 | 327 | 4 | –25.0% | <0.05 |
Adgb | Liver | chr10:10353338–10353613 | 276 | 4 | –25.9% | <0.05 |
Rbfox1 | Brain | chr16:6813039–6813217 | 179 | 5 | –24.3% | <0.05 |
Rbfox1 | Liver | chr16:6781985–6782330 | 346 | 5 | –22.6% | <0.05 |
ATAC-seq, H3K4me1, and H3K27ac regions were obtained at 0 days postnatal from the ENCODE database. p-Values for permutation testing using a randomisation strategy.
Assay type | Brain DMRs | Brain randomised regions | Liver DMRs | Liver randomised regions |
---|---|---|---|---|
ATAC-seq | 21/78 (26.92%), p=0.01 | 1/78 (1.28%), p=0.16 | 53/759 (6.98%) p=0.01 | 22/759 (2.90%) p=0.31 |
H3K4me1 | 4/78 (5.13%) p=0.03 | 2/78 (2.56%) p=0.18 | 38/759 (5.01%) p=0.05 | 35/759 (4.61%) p=0.32 |
H3K27ac | 9/78 (11.54%) p=0.01 | 2/78 (2.56%) p=0.74 | 48/759 (6.32%) p=0.01 | 19/759 (2.50%) p=0.26 |
The upper section describes properties of Lussier et al., 2018 human DMRs. The lower section describes properties of the equivalent murine model DMRs.
DMR | Organism | Tissue | Chr | Start | End | Width | No. CpGs | FDR | Meandiff | Gene |
---|---|---|---|---|---|---|---|---|---|---|
1 | Human | Buccal | 1 | 68151571 | 68152310 | 740 | 5 | 0.028636 | –0.00497 | GADD45A |
2 | Human | Buccal | 19 | 13000782 | 13002357 | 1576 | 11 | 0.000197 | –0.00203 | GCDH |
3 | Human | Buccal | 7 | 33148815 | 33149316 | 502 | 11 | 0.001149 | –0.00011 | RP9 |
4 | Human | Buccal | 17 | 33905444 | 33905888 | 445 | 14 | 0.000171 | –0.00359 | AP2B1, PEX12 |
5 | Human | Buccal | 17 | 27181503 | 27182342 | 840 | 11 | 0.018536 | –0.00246 | ERAL1, FAM222B |
6 | Human | Buccal | 19 | 12992181 | 12992479 | 299 | 9 | 0.037431 | –0.00179 | CTD-2265O21.7, DNASE2 |
7 | Human | Buccal | 19 | 11849531 | 11850013 | 483 | 9 | 0.022724 | –0.00244 | ZNF823 |
1 | Mouse | Liver | 6 | 67034885 | 67035082 | 197 | 4 | <0.05 | –0.220833 | E230016M11Rik |
2 | Mouse | Liver | 8 | 84901298 | 84901544 | 246 | 5 | <0.05 | –0.234457 | Klf1 |
3 | Mouse | Liver | 9 | 22453836 | 22453893 | 57 | 5 | <0.05 | –0.226427 | Rp9 |
4 | Mouse | Brain | 14 | 21403570 | 21403622 | 52 | 4 | <0.05 | –0.234193 | Adk |
5 | Mouse | Liver | 11 | 78069463 | 78070002 | 539 | 9 | <0.05 | –0.255864 | Mir144, Mir451a |
6 | Mouse | Liver | 11 | 78072079 | 78072313 | 234 | 4 | <0.05 | –0.215227 | Mir144, Mir451a |
7 | Mouse | Liver | 2 | 177091927 | 177092945 | 1018 | 5 | <0.05 | –0.224354 | Intergenic |
Statistical results from MWA studies.
(a) Table of brain differentially methylated regions (DMRs) identified by DSS and annotated with annotatr. (b) Table of liver DMRs identified by DSS and annotated with annotatr. (c) Table of gene set enrichment analysis (GSEA) ontology results from genes associated with liver DMRs. (d) GSEA Ontology Gene/Gene Set Overlap Matrix for liver DMRs. (e) List of genes included in candidate gene analysis. (f) Table of regions assessed in candidate genes analysis. (g) Table of brain DMRs having differences to DNA methylation with prenatal alcohol exposure (PAE) being rescued by dietary supplementation. (h) Table of liver DMRs having differences to DNA methylation with PAE being rescued by dietary supplementation. (i) Table of FDR-significant brain DMLs from candidate gene regions in regular diet mice. (j) Table of FDR-significant liver DMLs from candidate gene regions in regular diet mice. (k) Sequencing statistics and bioinformatic quality control.